These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16475962)

  • 1. Preventing type 2 diabetes in high risk patients: an overview of lifestyle and pharmacological measures.
    Liberopoulos EN; Tsouli S; Mikhailidis DP; Elisaf MS
    Curr Drug Targets; 2006 Feb; 7(2):211-28. PubMed ID: 16475962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is type-2 diabetes mellitus preventable?].
    Jermendy G
    Orv Hetil; 2003 Sep; 144(39):1909-17. PubMed ID: 14598569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can type 2 diabetes mellitus be considered preventable?
    Jermendy G
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S73-81. PubMed ID: 15955380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions in the prevention of type 2 diabetes.
    Henness S
    Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):166-9. PubMed ID: 17940436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
    Scheen AJ
    Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?
    Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
    Curr Pharm Des; 2010; 16(34):3939-847. PubMed ID: 21128892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of drug therapy to delay or prevent type 2 diabetes.
    Padwal R; Majumdar SR; Johnson JA; Varney J; McAlister FA
    Diabetes Care; 2005 Mar; 28(3):736-44. PubMed ID: 15735219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic options for metabolic syndrome in obese patients].
    Carella AM; Conte M
    Clin Ter; 2007; 158(5):457-64. PubMed ID: 18062354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
    Petersen JL; McGuire DK
    Diab Vasc Dis Res; 2005 Feb; 2(1):9-15. PubMed ID: 16305067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of type 2 diabetes: lifestyle changes or pharmacological interventions?].
    Scheen AJ; Letiexhe MR; Ernest P
    Rev Med Liege; 2003 Apr; 58(4):206-10. PubMed ID: 12868322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of cardiovascular events in elderly people.
    Andrawes WF; Bussy C; Belmin J
    Drugs Aging; 2005; 22(10):859-76. PubMed ID: 16245959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflecting on type 2 diabetes prevention: more questions than answers!
    Rosenstock J
    Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes prevention: is there more to it than lifestyle changes?
    Gruber A; Nasser K; Smith R; Sharma JC; Thomson GA
    Int J Clin Pract; 2006 May; 60(5):590-4. PubMed ID: 16700860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic prevention or delay of type 2 diabetes mellitus.
    Anderson DC
    Ann Pharmacother; 2005 Jan; 39(1):102-9. PubMed ID: 15562143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of β-cell function: the key to diabetes prevention.
    DeFronzo RA; Abdul-Ghani MA
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2354-66. PubMed ID: 21697254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice.
    Patoulias D; Stavropoulos K; Imprialos K; Athyros V; Doumas M; Karagiannis A
    Curr Vasc Pharmacol; 2020; 18(2):125-138. PubMed ID: 32013815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of type 2 diabetes mellitus to reduce cardiovascular morbidity and mortality: a review of the evidence.
    Giles TD
    J Clin Hypertens (Greenwich); 2009 Sep; 11(9):512-9. PubMed ID: 19751467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary prevention of diabetes mellitus by pharmacological intervention].
    Noda M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():100-8. PubMed ID: 12386980
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies.
    Merlotti C; Morabito A; Pontiroli AE
    Diabetes Obes Metab; 2014 Aug; 16(8):719-27. PubMed ID: 24476122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Into the future: prevention of diabetes.
    Bogaert YE; Schrier RW
    Contrib Nephrol; 2011; 170():256-263. PubMed ID: 21659778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.